Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD

Mise à jour : Il y a 4 ans
Référence : NCT00445679

Femme et Homme

Extrait

This study will assess the safety, tolerability and efficacy of desvenlafaxine succinate sustained release (DVS SR) in subjects with major depressive disorder.


Critère d'inclusion

  • Depressive Disorder, Major


Liens